Endomag

Ready to see our most advanced surgical guidance system yet? Meet the new Sentimag® platform at this year’s ABS Conference. At Endomag, we believe everyone deserves a better standard of cancer care – that’s why we design our unique magnetic technologies with both the clinician and patient in mind. Many leading hospitals across the world use our solutions to help breast cancer patients avoid surgery when it isn’t needed, and experience better outcomes when it is. Our Magseed® marker is a tiny, non-radioactive seed, ideal for accurately marking tumours and lymph nodes, while the Magtrace® lymphatic tracer is the world’s first, long-lasting, non-radioactive dual tracer for lymphatic mapping. Paired with the Sentimag, they are proven across over 100 clinical studies, featuring more than 20,000 patients. The Sentimag has already helped 500,000+ women access more precise, and less invasive breast cancer treatment. Are you ready to join the localisation revolution?